The Emory University psychiatry researcher who failed to report hundreds of thousands of dollars in pharmaceutical company payouts while receiving millions of dollars in funding from the National Institutes of Health to study the company's anti-depressant drugs is leaving the university, according to the linkurl:__Atlanta Journal-Constitution__.;http://www.ajc.com/health/controversial-emory-researcher-leaving-179261.html?cxtype=rss_news_128746 linkurl:Charles Nemeroff,;http://www.psychiatry.emory.edu/NeuropsychopharmacologyLaboratory/Charles%20Nemeroff.htm# a renowned depression researcher, failed to disclose to Emory approximately $800,000 in payments he received from drug maker GlaxoSmithKline (GSK) while he was the principal investigator (PI) on a multi-million dollar grant from the NIH to study five GSK antidepressants. Amid an investigation conducted by Emory, Nemeroff stepped down from his position as chairman of the psychiatry department last October. Later that month, the psychiatrist stepped down as PI from the $9.3 million NIH grant as the Senate probed his failure to disclose income from GSK, and the NIH froze funding on the five-year grant. Emory officials told the __Atlanta Journal-Constitution__ that...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!